Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Twinkling Nanostars Cast New Light Into Biomedical Imaging
Purdue University researchers have created magnetically responsive gold nanostars that may offer a new approach to biomedical imaging.
generic viagra online
Survey Flushes Out The Secrets Of Americans' Bathroom Habits
Whether it"s "powdering your nose" or settling in for a good read, Americans spend a significant amount of time in the bathroom. According to a recent Yankelovich survey, many Americans spend more than 30 minutes each day in the bathroom that adds up to nearly eight days each year - which is more than double that of the average vacation trip . And contrary to popular belief, men spend almost as much time in the bathroom as women.
News of the day
Interest Groups Crowd Airwaves, Pursue Lawmakers
"The increasingly heated fight over health-care legislation is saturating the summer airwaves, with groups on all sides of the debate pouring tens of millions of dollars into advertising campaigns designed to push the cause of reform forward, slow it down or stop it in its tracks," the Washington Post reports. So far, drug makers, labor groups, Democrats and Republicans - among others - have spent $52 million to finance the ad campaigns, a heady start that could lead to a "record-breaking legislative battle."
Sexual Health

SYMBICORT(R) Added To Tiotropium Provided Clinically Significant Benefits For Patients With Severe COPD

Data presented at this year"s American Thoracic Society (ATS) congress, demonstrated that SYMBICORT® (budesonide/formoterol-TURBUHALER®, a dry powder inhaler) added to SpirivaTM (tiotropium) provided greater clinical improvements than tiotropium alone over a 12-week treatment period.1,2 Results of the CLIMB study showed that the occurrence of severe exacerbations was reduced by as much as 62 percent in patients where budesonide/formoterol was added to tiotropium (pReferences 1. Welte T, Miravitlles M, Peterson S et al. Budesonide/formoterol added to tiotropium improves the management of COPD patients. Abstract presented at American Thoracic Society (ATS) International Conference, San Diego, USA. May 15-20 2009 2. Welte T, Hartman L, Polanowski T et al. Budesonide/formoterol added to tiotropium is well tolerated and reduces risk of severe exacerbations in COPD patients. Abstract presented at American Thoracic Society (ATS) International Conference, San Diego, USA. May 15-20 2009 3. Partridge M, Karlsson N and Small I. Patient insights into the impact of COPD on morning symptoms, activities and daily life. Abstract presented at BTS 2008 4. Worth H, Peterson S, Nihlçİn U et al. Improved exercise tolerance with budesonide/formoterol vs placebo and formoterol in COPD patients. Abstract presented at American Thoracic Society (ATS) International Conference, San Diego, USA. May 15-20 2009 SYMBICORT, SYMBICORT SMART AND TURBUHALER are trademarks of the AstraZeneca group of companies -SYMBICORT is a combination of two proven medications - the inhaled corticosteroid (ICS), budesonide (Pulmicort®), and the fast-acting and long-acting bronchodilator (LABA), formoterol (Oxis®) in one inhaler - SYMBICORT is a rapid-acting combination therapy indicated for the long-term maintenance treatment of asthma, SYMBICORT SMART (Maintenance And Reliever Therapy), as well as Chronic Obstructive Pulmonary Disease (COPD), are all delivered via the SYMBICORT Turbuhaler device. SYMBICORT SMART and SYMBICORT Turbuhaler are not available in the U.S. AstraZeneca


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

İ Copyright 2009